New

Clinical Mass Spectrometry Market

2021

Clinical Mass Spectrometry Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Gas chromatography Mass Spectrometry, Liquid chromatography Mass Spectrometry, MALDI-TOF Mass Spectrometer, Capillary Electrophoresis Mass Spectrometry, Ion Mobility Spectrometry); Application (Drug Discovery, Clinical Testing, Proteomics, Others); End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)

| Report Code: TIPBT00002551 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Clinical Mass Spectrometry Market 2028 By Product Type, Application, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Clinical mass spectrometry is a qualitative and quantitative analytical tool used to evaluate complex mixtures during the drug development process, including defining the lead compound and its conformational information. Clinical diagnostic mass spectrometers are capable to examine a limited range of samples such as proteins, biomarkers, or drug molecules at once, even in cases of low concentrations thus, making them an important tool for diagnostic medical laboratories.

MARKET SCOPE



The "Global Clinical Mass Spectrometry Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the clinical mass spectrometry market with detailed market segmentation by product type, application, end user, and geography. The report provides key statistics on the market status of the leading clinical mass spectrometry market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product type, the global clinical mass spectrometry market is segmented into gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, MALDI TOF mass spectrometer, capillary electrophoresis-mass spectrometry, and ion mobility spectrometry.
  • On the basis of application, the market is segmented into drug discovery, clinical testing, proteomics and others.
  • Based on end user, the market is bifurcated into hospitals, diagnostic centers, and research laboratories and others.

MARKET DYNAMICS


Drivers



  • Advancements in technology of spectrometry
  • Increased investments in R&D and advancement of healthcare technologies
  • Increase in developments in the emerging nations
  • Funds provided by the government bodies

Restraints



  • The capital investment needed for installation and maintenance of these devices

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The clinical mass spectrometry market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the clinical mass spectrometry market in these regions.

IMPACT OF COVID-19 ON CLINICAL MASS SPECTROMETRY MARKET


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Clinical mass spectrometry (MS) can provide useful diagnostic information that complements genomic data, allowing researchers to learn more about the COVID-19 disease caused by the SARS-CoV-2 virus.

MARKET PLAYERS



The report covers key developments in the clinical mass spectrometry market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from clinical mass spectrometry market are anticipated to lucrative growth opportunities in the future with the rising demand for clinical mass spectrometry in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the clinical mass spectrometry market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Bruker
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Agilent Technologies
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Kore Technologies
  • BME Bergmann
  • Mass Spectrometry Instruments
  • Photonics GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Clinical Mass Spectrometry Market - By Product Type
1.3.2 Clinical Mass Spectrometry Market - By Application
1.3.3 Clinical Mass Spectrometry Market - By End User
1.3.4 Clinical Mass Spectrometry Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CLINICAL MASS SPECTROMETRY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CLINICAL MASS SPECTROMETRY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CLINICAL MASS SPECTROMETRY MARKET - GLOBAL MARKET ANALYSIS
6.1. CLINICAL MASS SPECTROMETRY - GLOBAL MARKET OVERVIEW
6.2. CLINICAL MASS SPECTROMETRY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GAS CHROMATOGRAPHY MASS SPECTROMETRY
7.3.1. Overview
7.3.2. Gas chromatography Mass Spectrometry Market Forecast and Analysis
7.4. LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
7.4.1. Overview
7.4.2. Liquid chromatography Mass Spectrometry Market Forecast and Analysis
7.5. MALDI-TOF MASS SPECTROMETER
7.5.1. Overview
7.5.2. MALDI-TOF Mass Spectrometer Market Forecast and Analysis
7.6. CAPILLARY ELECTROPHORESIS MASS SPECTROMETRY
7.6.1. Overview
7.6.2. Capillary Electrophoresis Mass Spectrometry Market Forecast and Analysis
7.7. ION MOBILITY SPECTROMETRY
7.7.1. Overview
7.7.2. Ion Mobility Spectrometry Market Forecast and Analysis
8. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY
8.3.1. Overview
8.3.2. Drug Discovery Market Forecast and Analysis
8.4. CLINICAL TESTING
8.4.1. Overview
8.4.2. Clinical Testing Market Forecast and Analysis
8.5. PROTEOMICS
8.5.1. Overview
8.5.2. Proteomics Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Clinical Mass Spectrometry Market Overview
10.1.2 North America Clinical Mass Spectrometry Market Forecasts and Analysis
10.1.3 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
10.1.4 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
10.1.5 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
10.1.6 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
10.1.6.1 United States Clinical Mass Spectrometry Market
10.1.6.1.1 United States Clinical Mass Spectrometry Market by Product Type
10.1.6.1.2 United States Clinical Mass Spectrometry Market by Application
10.1.6.1.3 United States Clinical Mass Spectrometry Market by End User
10.1.6.2 Canada Clinical Mass Spectrometry Market
10.1.6.2.1 Canada Clinical Mass Spectrometry Market by Product Type
10.1.6.2.2 Canada Clinical Mass Spectrometry Market by Application
10.1.6.2.3 Canada Clinical Mass Spectrometry Market by End User
10.1.6.3 Mexico Clinical Mass Spectrometry Market
10.1.6.3.1 Mexico Clinical Mass Spectrometry Market by Product Type
10.1.6.3.2 Mexico Clinical Mass Spectrometry Market by Application
10.1.6.3.3 Mexico Clinical Mass Spectrometry Market by End User
10.2. EUROPE
10.2.1 Europe Clinical Mass Spectrometry Market Overview
10.2.2 Europe Clinical Mass Spectrometry Market Forecasts and Analysis
10.2.3 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
10.2.4 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
10.2.5 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
10.2.6 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Clinical Mass Spectrometry Market
10.2.6.1.1 Germany Clinical Mass Spectrometry Market by Product Type
10.2.6.1.2 Germany Clinical Mass Spectrometry Market by Application
10.2.6.1.3 Germany Clinical Mass Spectrometry Market by End User
10.2.6.2 France Clinical Mass Spectrometry Market
10.2.6.2.1 France Clinical Mass Spectrometry Market by Product Type
10.2.6.2.2 France Clinical Mass Spectrometry Market by Application
10.2.6.2.3 France Clinical Mass Spectrometry Market by End User
10.2.6.3 Italy Clinical Mass Spectrometry Market
10.2.6.3.1 Italy Clinical Mass Spectrometry Market by Product Type
10.2.6.3.2 Italy Clinical Mass Spectrometry Market by Application
10.2.6.3.3 Italy Clinical Mass Spectrometry Market by End User
10.2.6.4 Spain Clinical Mass Spectrometry Market
10.2.6.4.1 Spain Clinical Mass Spectrometry Market by Product Type
10.2.6.4.2 Spain Clinical Mass Spectrometry Market by Application
10.2.6.4.3 Spain Clinical Mass Spectrometry Market by End User
10.2.6.5 United Kingdom Clinical Mass Spectrometry Market
10.2.6.5.1 United Kingdom Clinical Mass Spectrometry Market by Product Type
10.2.6.5.2 United Kingdom Clinical Mass Spectrometry Market by Application
10.2.6.5.3 United Kingdom Clinical Mass Spectrometry Market by End User
10.2.6.6 Rest of Europe Clinical Mass Spectrometry Market
10.2.6.6.1 Rest of Europe Clinical Mass Spectrometry Market by Product Type
10.2.6.6.2 Rest of Europe Clinical Mass Spectrometry Market by Application
10.2.6.6.3 Rest of Europe Clinical Mass Spectrometry Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Clinical Mass Spectrometry Market Overview
10.3.2 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis
10.3.3 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Clinical Mass Spectrometry Market
10.3.6.1.1 Australia Clinical Mass Spectrometry Market by Product Type
10.3.6.1.2 Australia Clinical Mass Spectrometry Market by Application
10.3.6.1.3 Australia Clinical Mass Spectrometry Market by End User
10.3.6.2 China Clinical Mass Spectrometry Market
10.3.6.2.1 China Clinical Mass Spectrometry Market by Product Type
10.3.6.2.2 China Clinical Mass Spectrometry Market by Application
10.3.6.2.3 China Clinical Mass Spectrometry Market by End User
10.3.6.3 India Clinical Mass Spectrometry Market
10.3.6.3.1 India Clinical Mass Spectrometry Market by Product Type
10.3.6.3.2 India Clinical Mass Spectrometry Market by Application
10.3.6.3.3 India Clinical Mass Spectrometry Market by End User
10.3.6.4 Japan Clinical Mass Spectrometry Market
10.3.6.4.1 Japan Clinical Mass Spectrometry Market by Product Type
10.3.6.4.2 Japan Clinical Mass Spectrometry Market by Application
10.3.6.4.3 Japan Clinical Mass Spectrometry Market by End User
10.3.6.5 South Korea Clinical Mass Spectrometry Market
10.3.6.5.1 South Korea Clinical Mass Spectrometry Market by Product Type
10.3.6.5.2 South Korea Clinical Mass Spectrometry Market by Application
10.3.6.5.3 South Korea Clinical Mass Spectrometry Market by End User
10.3.6.6 Rest of Asia-Pacific Clinical Mass Spectrometry Market
10.3.6.6.1 Rest of Asia-Pacific Clinical Mass Spectrometry Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Clinical Mass Spectrometry Market by Application
10.3.6.6.3 Rest of Asia-Pacific Clinical Mass Spectrometry Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Clinical Mass Spectrometry Market Overview
10.4.2 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis
10.4.3 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Clinical Mass Spectrometry Market
10.4.6.1.1 South Africa Clinical Mass Spectrometry Market by Product Type
10.4.6.1.2 South Africa Clinical Mass Spectrometry Market by Application
10.4.6.1.3 South Africa Clinical Mass Spectrometry Market by End User
10.4.6.2 Saudi Arabia Clinical Mass Spectrometry Market
10.4.6.2.1 Saudi Arabia Clinical Mass Spectrometry Market by Product Type
10.4.6.2.2 Saudi Arabia Clinical Mass Spectrometry Market by Application
10.4.6.2.3 Saudi Arabia Clinical Mass Spectrometry Market by End User
10.4.6.3 U.A.E Clinical Mass Spectrometry Market
10.4.6.3.1 U.A.E Clinical Mass Spectrometry Market by Product Type
10.4.6.3.2 U.A.E Clinical Mass Spectrometry Market by Application
10.4.6.3.3 U.A.E Clinical Mass Spectrometry Market by End User
10.4.6.4 Rest of Middle East and Africa Clinical Mass Spectrometry Market
10.4.6.4.1 Rest of Middle East and Africa Clinical Mass Spectrometry Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Clinical Mass Spectrometry Market by Application
10.4.6.4.3 Rest of Middle East and Africa Clinical Mass Spectrometry Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Clinical Mass Spectrometry Market Overview
10.5.2 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis
10.5.3 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
10.5.5 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
10.5.6 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Clinical Mass Spectrometry Market
10.5.6.1.1 Brazil Clinical Mass Spectrometry Market by Product Type
10.5.6.1.2 Brazil Clinical Mass Spectrometry Market by Application
10.5.6.1.3 Brazil Clinical Mass Spectrometry Market by End User
10.5.6.2 Argentina Clinical Mass Spectrometry Market
10.5.6.2.1 Argentina Clinical Mass Spectrometry Market by Product Type
10.5.6.2.2 Argentina Clinical Mass Spectrometry Market by Application
10.5.6.2.3 Argentina Clinical Mass Spectrometry Market by End User
10.5.6.3 Rest of South and Central America Clinical Mass Spectrometry Market
10.5.6.3.1 Rest of South and Central America Clinical Mass Spectrometry Market by Product Type
10.5.6.3.2 Rest of South and Central America Clinical Mass Spectrometry Market by Application
10.5.6.3.3 Rest of South and Central America Clinical Mass Spectrometry Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CLINICAL MASS SPECTROMETRY MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CLINICAL MASS SPECTROMETRY MARKET, KEY COMPANY PROFILES
13.1. BRUKER
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DANAHER
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. AGILENT TECHNOLOGIES, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PERKINELMER INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SHIMADZU CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. KORE TECHNOLOGY
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BERGMANN MESSGERAETE ENTWICKLUNG KG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. WATERS CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ANALYTIK JENA AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS



The List of Companies

1. Bruker
2. Thermo Fisher Scientific
3. Danaher
4. Agilent Technologies, Inc
5. PerkinElmer Inc.
6. Shimadzu Corporation
7. KORE TECHNOLOGY
8. Bergmann Messgeraete Entwicklung KG
9. Waters Corporation
10. Analytik Jena AG
11. Mass Spectrometry Instruments (MSI)
12. Agilent Technologies Inc.
13. Hitachi Ltd.
14. JEOL Ltd.
15. Waters Corp.
TIPBT00002551
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.